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Abstract 
In the present study the solubility-pH profiles of sibutramine free base and its hydrochloride salt were 
determined in the pH range between 2.0 and 9.5 by means of the recommended shake-flask method, and 
the solids collected were dried and studied by X-ray diffraction in order to elucidate their free base or salt 
structure. Above pHmax (or Gibbs pKa) the solid collected was always identified as free base, whatever the 
sibutramine species (free base or hydrochloride salt) initially solved. However, in the pH range below pHmax 
different solids were isolated depending on the buffers employed. 
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Introduction 
In drug formulation it is well known that salts from basic compounds are generally more stable and 
soluble than their corresponding free bases and, therefore, the salt form is preferred for use as active 
ingredient in a pharmaceutical form. Thus, the study of the solubility of a compound as a function of pH, 
the solubility-pH profile, provides very useful information about the physicochemical properties of a 
compound and its rate of success as a drug candidate. In the case of weakly basic active pharmaceutical 
ingredients, at higher pH values (pH >> pKa) the solubility is constant and independent of pH, and the solid 
phase in equilibrium with the saturated solution is the free base. In contrast, at acidic pH values (pH << pKa) 
the solid in equilibrium with the cationic base is a salt, whose composition depends on the anionic 
components of buffering species. The particular salt formed is relevant because of its influence on the 
maximum achievable concentration of the saturated solution. Between this acidic and basic pH regions 
there is a particular pH value, known as pHmax or pKa Gibbs, for which the solution is saturated with both, 
the free and the cationic species, and the solid in equilibrium contains also free base and salt [1].  
The crystalline racemic compound sibutramine hydrochloride monohydrate was used as the active 
pharmaceutical ingredient of medicines for the management of obesity from 1999 to 2010. Its withdrawal 
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from European and US markets was due to cardiovascular side effects. However, the physicochemical 
properties of sibutramine (molecular weight, acidity, solubility, lipophilicity…) make it a very interesting 
model for the solubility study of basic compounds.  
Experimental  
The solubility-pH profiles of sibutramine (free base) and its hydrochloride salt have been determined at 
25 
o
C in the pH range between 2.0 and 9.5 by means of the shake-flask method using the recommended 
protocol [2]. Briefly, a mass spectrometry-friendly minimalist universal buffer (MS-MUB) consisting of 25 
mM acetic acid, 25 mM ethylenediamine, and 75 mM trifluoroacetic acid (TFA) was used, incubation was 
carried out for 48 h (24 h stirring and 24 h sedimentation), pH was measured after 4 h of stirring and 
readjusted if necessary with sodium hydroxide or hydrochloric acid, and finally the pH was measured again 
before the phase separation by centrifugation. Sibutramine concentration was determined by HPLC with 
UV detection and the solid was vacuum filtered and dried for 24 h in order to elucidate their free base or 
salt structure by powder X-ray diffraction (PXRD). 
With the aim of evaluating the effect of the MS-MUB components on the precipitated solid, simple 
solutions prepared from acetic acid, trifluoroacetic acid, and hydrochloric acid were used. Finally, the 
Henderson-Hasselbalch (HH) profile was constructed from the spectrophotometrically determined pKa [3] 
and the intrinsic solubility measured by the CheqSol method [4]. 
Results and Discussion 
pH change during stirring step in the shake-flak procedure 
A universal buffer was selected in the present work in order to keep nearly constant the ionic strength 
of the buffering solution across the studied pH range, but intentionally avoiding phosphate ions because 
they are well known to interact with positively charged bases. Besides these features, it is always 
interesting to count on a MS-friendly buffer, since liquid chromatography coupled to MS is a powerful 
technique for the measurement of low concentrations of poorly soluble substances. Therefore, MS-MUB 
was used, providing in the whole pH working range an ionic strength of 96 mM but being thought to be 
minimally intrusive in relation to anionic buffering species. 
The pH measurements after 4 hours of stirring revealed significant variations (above 1 pH unit) in 
relation to the initial pH of the buffer before the addition of the solid, which depends on the nature of 
starting solid. In fact, there is a remarkable increase in the pH value of acidic solutions (pH < 4) when the 
free base is used as starting species, and the reverse trend is observed for the hydrochloride salt at basic 
pH values. In the rest of cases, free base/basic pH and salt/acidic pH, pH variations are not significant 
during the stirring step. 
Effect of buffer components on solubility-pH profile 
Figure 1 shows the solubility-pH profile of sibutramine according to the buffering species used in the 
shake-flask procedure, and Figure 2 relates the solubility with the solid species initially selected for the 
experiments (free base or hydrochloride salt) and the solid collected and dried after centrifugation. There 
is a good agreement between the shake-flask results and the HH profile in the pH range above pHmax, 
independently of the sibutramine form initially weighted and the buffering species employed, and in this 
pH region the solid collected was always identified by PXRD as the free base. In contrast, a salt was  
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Figure 1. Solubility-pH profile of sibutramine according to the buffering species used in the shake-flask 
procedure. Legend: () MS-MUB, () hydrochloric acid (unbuffered), (▲) TFA (unbuffered). 
 
 
Figure 2. Solubility-pH profile of sibutramine according to the initial weighted solid form and the collected 
solid after shake-flask procedure identified by PXRD. Legend: circles and squares refer to initial species, free 
base or sibutramine·HCl, respectively; solid, empty, and crossed symbols indicate collected solids as free base, 
HCl salt, and TFA salt, respectively. 
expected in the pH range below pHmax, but in fact two different solids were isolated depending on the 
buffers employed. When MS-MUB or its single component TFA were used the dried solid was identified as 
sibutramine·TFA salt, whereas when only hydrochloric acid was employed the corresponding solid was the 
hydrochloride salt. Interestingly, the solubility of the compound in equilibrium with the solid TFA is slightly 
lower than that of HCl salt. The TFA salt was formed independently of the starting sibutramine species, free 
base or hydrochloride salt. 
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Conclusions 
It is very convenient to periodically measure and readjust (if necessary) the pH of the saturated solution 
of drug, especially during the first hours of the stirring step. The sign and extent of the variation depends 
on the initial form of the compound (free base or salt) and the particular working pH. 
Single anionic components of universal buffers, for instance TFA in MS-MUB, may interact with 
positively charged basic drugs leading to unexpected salts in equilibrium with the saturated solution, 
affecting thus the solubility of the compound. 
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